摘要
急性肾损伤是一种复杂的疾病,死亡率和发病率都在不断上升。炎症反应,包括先天免疫反应和适应性免疫反应,参与了机体的启动和发育。F急性肾损伤,尤其是缺血性肾损伤。肾小管细胞和不同的免疫细胞亚群在炎症的发病机制中起着至关重要的作用。基因治疗现状现在他们在肾脏修复方面的好处。在这里,我们回顾了肾脏炎症浸润,炎症介质,氧化应激和潜在的信号通路,这些都是导致肾衰竭的原因。SE在急性肾损伤机制中的作用。最近的研究在了解炎症相关肾损伤的病理生理过程方面显示出不同的见解,并为临床提供了新的治疗方法。RGS通过平衡修复和预防损伤来改善急性肾损伤。有趣的是,靶序列的反义寡核苷酸,局部选择转移N实体器官和腺病毒介导的某些基因过表达是缓解急性肾损伤的有效策略。
关键词: 急性肾损伤,炎症,细胞因子,氧化应激,基因治疗,树突状细胞。
Current Gene Therapy
Title:Current Understanding of Inflammatory Responses in Acute Kidney Injury
Volume: 17 Issue: 6
关键词: 急性肾损伤,炎症,细胞因子,氧化应激,基因治疗,树突状细胞。
摘要: Acute kidney injury has been a tough complex with increased mortality and morbidity. Inflammatory responses, including innate and adaptive immune responses, involve in the initiation and development of acute kidney injury, especially under the ischemic circumstances. Tubular cells and distinct immune cell subgroups play a critical role in the pathogenesis of inflammation. Current gene therapies show their benefits in renal repair. Here, we reviewed the renal inflammatory infiltration, inflammatory mediators, oxidative stress and potential signaling pathways, which give rise to the kidney diseases, in the mechanism of acute kidney injury. Recent studies showed diverse insights in understanding the pathophysiological process of inflammation related renal injury and provided novel clinical targets for ameliorating acute kidney injury by balancing the facilitation of repairing and prevention of impairing. Interestingly, antisense oligonucleotides of target sequence, local electransfering on solid organ and adenovirus-mediated certain gene overexpression have been promising strategies in alleviating acute kidney injury.
Export Options
About this article
Cite this article as:
Current Understanding of Inflammatory Responses in Acute Kidney Injury, Current Gene Therapy 2017; 17 (6) . https://dx.doi.org/10.2174/1566523218666180214092219
DOI https://dx.doi.org/10.2174/1566523218666180214092219 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Thalidomide Metabolism and Hydrolysis: Mechanisms and Implications
Current Drug Metabolism Medicinal Plants and Atherosclerosis: A Review on Molecular Aspects
Current Pharmaceutical Design The Optimal Treatment of Thyroid Gland Function Disturbances During Pregnancy
Current Pharmaceutical Biotechnology The Triad: Erectile Dysfunction - Endothelial Dysfunction - Cardiovascular Disease
Current Pharmaceutical Design Granulomatosis with Polyangiitis (GPA) in a 15-year-old Girl with Facial Acne-like Ulcers: A Case Report
Infectious Disorders - Drug Targets MRI of Central Nervous System (CNS) Vasculitis
Current Medical Imaging Hepatic Manifestations in Juvenile Systemic Lupus Erythematosus
Recent Patents on Inflammation & Allergy Drug Discovery The Role of C-Reactive Protein in Atherosclerotic Cardiovascular Disease: An Overview
Current Vascular Pharmacology Drug-Induced Aseptic Meningitis
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond
Current Molecular Imaging (Discontinued) The Potential Role of Statins in Pneumonia
Current Respiratory Medicine Reviews Management of Vasculopathy in Connective Tissue Disease
Current Rheumatology Reviews Chemokines in the Pathogenesis and as Therapeutical Markers and Targets of HCV Chronic Infection and HCV Extrahepatic Manifestations
Current Drug Targets Therapeutic Apheresis in Metabolic Syndrome
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Editorial: Cocaine and Acute Basilar Artery Occlusion: What we Know to Date?
Current Vascular Pharmacology Nitric Oxide Synthase and Cyclooxygenase Pathways: A Complex Interplay in Cellular Signaling
Current Medicinal Chemistry Vascular Inflammation in Cardiovascular Disease: Is Immune System Protective or Bystander?
Current Pharmaceutical Design Prognostic Role of miRNAs in Coronary Artery Disease
Current Topics in Medicinal Chemistry Brain Delivery of Chemotherapeutics in Brain Cancer
Anti-Cancer Agents in Medicinal Chemistry Novel Therapeutic Approaches Targeting Vascular Endothelial Growth Factor and its Receptors in Haematological Malignancies
Current Cancer Drug Targets